|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
FY2023
12 months to Mar 31, 2023
|
FY2022
12 months to Mar 31, 2022
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net earnings | |||||
| Adjustments to reconcile net earnings to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Write-off of assets relating to restructuring and other exit charges | |||||
| Impairment of goodwill | |||||
| (Gain) loss on assets held for sale | |||||
| Impairment of intangible assets | |||||
| Derivatives not designated in hedging relationships: | |||||
| Net losses (gains) | |||||
| Cash proceeds (settlements) | |||||
| Provision for doubtful accounts | |||||
| Deferred income taxes | |||||
| Non-cash interest expense | |||||
| Stock-based compensation | |||||
| Gain on disposal of property, plant, and equipment | |||||
| Losses (gain) on pension settlement | |||||
| Changes in assets and liabilities, net of effects of acquisitions: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Prepaid and other current assets | |||||
| Other assets | |||||
| Accounts payable | |||||
| Accrued expenses | |||||
| Other liabilities | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash flows from investing activities | |||||
| Capital expenditures | |||||
| Purchase of businesses | |||||
| Proceeds from disposal of facility | |||||
| Proceeds from disposal of property, plant, and equipment | |||||
| Investment in Equity Securities | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities | |||||
| Net borrowings (repayments) on short-term debt | |||||
| Proceeds from Revolver borrowings | |||||
| Total proceeds from Revolver borrowings | |||||
| Repayments of Revolver borrowings | |||||
| Total repayments of Revolver borrowings | |||||
| Proceeds from Amended 2017 Term Loan | |||||
| Proceeds from 2032 Bonds | |||||
| Repayments of 2023 Senior Notes | |||||
| Repayments of Term Loans | |||||
| Debt issuance costs | |||||
| Finance lease obligations and other | |||||
| Option proceeds, net | |||||
| Payment of taxes related to net share settlement of equity awards | |||||
| Purchase of treasury stock | |||||
| Dividends paid to stockholders | |||||
| Other | |||||
| Net cash (used in) provided by financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
Loading...